Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis.
Lenci E, Marcantognini G, Cognigni V, Lupi A, Rinaldi S, Cantini L, Fiordoliva I, Carloni AL, Rocchi M, Zuccatosta L, Gasparini S, Berardi R. Lenci E, et al. Among authors: fiordoliva i. Explor Target Antitumor Ther. 2021;2(3):227-239. doi: 10.37349/etat.2021.00043. Epub 2021 Jun 28. Explor Target Antitumor Ther. 2021. PMID: 36046436 Free PMC article.
Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study.
Berardi R, Mocchegiani F, Rinaldi S, Fiordoliva I, Rovinelli F, Caramanti M, Federici A, Burattini M, Morgese F, Torniai M, Marcantognini G, Vivarelli M. Berardi R, et al. Among authors: fiordoliva i. Oncol Ther. 2020 Jun;8(1):115-124. doi: 10.1007/s40487-020-00112-6. Epub 2020 Apr 1. Oncol Ther. 2020. PMID: 32700076 Free PMC article.
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.
Berardi R, Rinaldi S, Santoni M, Newsom-Davis T, Tiberi M, Morgese F, Caramanti M, Savini A, Ferrini C, Torniai M, Fiordoliva I, Bower M, Cascinu S. Berardi R, et al. Among authors: fiordoliva i. Oncotarget. 2016 May 3;7(18):26916-24. doi: 10.18632/oncotarget.8309. Oncotarget. 2016. PMID: 27029035 Free PMC article.
Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials.
Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M, Morgese F, Torniai M, Savini A, Fiordoliva I, Onofri A, Pistelli M, Taccaliti A, Cascinu S. Berardi R, et al. Among authors: fiordoliva i. PLoS One. 2016 May 11;11(5):e0152079. doi: 10.1371/journal.pone.0152079. eCollection 2016. PLoS One. 2016. PMID: 27167519 Free PMC article. Review.
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis.
Cantini L, Merloni F, Rinaldi S, Lenci E, Marcantognini G, Meletani T, Fiordoliva I, Morgese F, Torniai M, Ricci G, Giampieri R, Berardi R. Cantini L, et al. Among authors: fiordoliva i. Crit Rev Oncol Hematol. 2020 Jul;151:102974. doi: 10.1016/j.critrevonc.2020.102974. Epub 2020 May 4. Crit Rev Oncol Hematol. 2020. PMID: 32416348
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients.
Cantini L, Pecci F, Hurkmans DP, Belderbos RA, Lanese A, Copparoni C, Aerts S, Cornelissen R, Dumoulin DW, Fiordoliva I, Rinaldi S, Aerts JGJV, Berardi R. Cantini L, et al. Among authors: fiordoliva i. Eur J Cancer. 2021 Feb;144:41-48. doi: 10.1016/j.ejca.2020.10.031. Epub 2020 Dec 14. Eur J Cancer. 2021. PMID: 33326868
18 results